Draft:SDMA

• Comment: A parent is a primary source and not usable in a tertiary source. We need independent secondary sources. Stuartyeates (talk) 09:27, 20 April 2024 (UTC)

• Comment: The title of this draft either has been disambiguated or will need to be disambiguated for acceptance.
  If this draft is accepted, the disambiguation page will need to be edited. Either an entry will need to be added, or an entry will need to be revised.
  The disambiguation page for the primary name is SDMA (disambiguation).
  What does the SDMA stand for? Robert McClenon (talk) 18:34, 19 April 2024 (UTC)

---

SDMA

Identifiers
IUPAC name Benzoxathiol-6-yl-N-methyl-propan-2-amine
CAS Number	2891979-85-2
Chemical and physical data
Formula	C11H15NOS
Molar mass	209.31 g·mol−1
3D model (JSmol)	Interactive image
SMILES O1C2=CC(=CC=C2SC1)CC(NC)C

SDMA (Benzoxathiol-6-yl-N-methyl-propan-2-amine) is a substituted amphetamine derivative with empathogenic effects, which acts as analogue of MDMA with a supposed shorter half-life. SDMA, along with its corresponding nor-compound SDA, are potential candidates for treatment-resistant depression and post-traumatic stress disorder. New SDMA prodrugs are in the development phase at MiHKAL GmbH in Switzerland.

SDA [1]